India's healthcare & pharma sectors achieve record IPO issuance since 2019

Andhra, PhysicsWallah ink Rs 1,000 cr deal to set up varsity of innovation

Can Fin Homes CFO Apurav Agarwal resigns

Auro Pharma gets UK MHRA nod for cancer drug

Reliance Inds arm to acquire 45% stake in Health Alliance Group

We hereby Certify that all activities in relation to both physical and electronic share transfer facilities are maintained by the Companys Registrar and Share Transfer Agent Viz. Purva Sharegistry (India) Private Limited having registered office at Unit No 9 Shiv Shakti Industrial Estate Ground Floor J R Boricha Marg Opp Kasturba Hospital Lower Parel Mumbai Maharashtra 400011 Which is a SEBI approved category-I Registrar & Transfer Agent registered with Securities and Exchange Board of India (SEBI Registration Number: INR000001112).

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>YANTRA NATURAL RESOURCES LTD.</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L14297AP1988PLC074808</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Rahul Ahire <br/> Designation: Compliance Officer <br/> EmailId: yantranrltd@gmail.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Rahul Ahire <br/> Designation: Director <br/> EmailId: yantranrltd@gmail.com</div> </div> <div> <br/> Date: 27/04/2023<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>

In pursuant to regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 please find the enclosed herewith Certificate under regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 for the financial year ended on March 31 2023 issued by Mr. Chirag Jain certifying that all the Certificates have been issued within 30 days of the lodgment for transfer sub-division consolidation renewal exchange or endorsement of calls/ allotment monies as applicable.

We hereby undertake that our Company does not fall under the Large Corporate criteria as prescribed in para 2.2 of the SEBI Circular no. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018 regarding Fund raising by issuance of Debt Securities by Large Entities. Therefore the requirement for furnishing the Initial Disclosure in prescribed format of Annexure-A of that circular do not applicable to our Company.

Pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 we received a confirmation from Purva Sharegistry (India) Private Limited Registrar and Transfer Agent of the Company for the quarter ended on 31st March 2023 regarding that the securities received from the depository participants for dematerialization during the quarter ended March 31 2023.